Abstract P6-17-33: A multi-scale mathematical model of combination targeted and cytotoxic therapy to evaluate treatment response in HER2+ breast cancer von Jarrett, AM, Shah, A, Bloom, MJ, Yankeelov, TE, Sorace, AG

Volltext

Abstract P3-05-16: A mathematical model for predicting immune response in a trastuzumab treated HER2+ breast cancer animal model: Preliminary efforts von Jarrett, AM, Yankeelov, TE, Ehrlich, LI, Godfrey, W, Sorace, AG

Volltext

Abstract P4-06-17: Investigating trastuzumab-induced myeloid cell alterations for improving combination therapy in HER2+ breast cancer von Bloom, MJ, Jarrett, AM, Triplett, TA, Syed, AK, Yankeelov, TE, Sorace, AG

Volltext

Abstract P1-01-02: Quantitative breast MRI to predict response to neoadjuvant therapy in community imaging centers: Preliminary results von Sorace, AG, Virostko, J, Wu, C, Jarrett, AM, Barnes, SL, Ekrut, D, Patt, D, Goodgame, B, Avery, S, Yankeelov, TE

Volltext

Abstract P6-01-03: Trastuzumab-induced hypoxia changes in a HER2+ murine model of breast cancer von Sorace, AG, Quarles, CC, Yankeelov, TE

Volltext

Abstract P4-02-02: Increased tumor perfusion following treatment with trastuzumab as measured by contrast-enhanced ultrasound von Sorace, AG, Barnes, SL, Quarles, CC, McIntyre, JO, Yankeelov, TE

Volltext

Abstract P4-12-12: Quantitative in vivo imaging of intratumoral heterogeneity to assess tumor response to trastuzumab treatment in a preclinical model of HER2+ breast cancer von Syed, A, Quarles, CC, McIntyre, JO, Barnes, SL, Yankeelov, TE, Sorace, AG

Volltext

Abstract P4-02-08: Repeatability and reproducibility of quantitative breast MRI in community imaging centers: Preliminary results von Sorace, AG, Virostko, J, Wu, C, Jarrett, AM, Barnes, SL, Luci, J, Patt, DA, Goodgame, B, Avery, S, Yankeelov, TE

Volltext

Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles von Warram, J M, Sorace, A G, Saini, R, Borovjagin, A V, Hoyt, K, Zinn, K R

Volltext